Risk-benefit assessment of Bacillus Calmette-Guérin vaccination, anti-phenolic glycolipid I serology, and Mitsuda test response: 10-year follow-up of household contacts of leprosy patients

Risk-benefit assessment of Bacillus Calmette-Guérin vaccination, anti-phenolic glycolipid I serology, and Mitsuda test response: 10-year follow-up of household contacts of leprosy patients

Abstract: INTRODUCTION: Despite multidrug therapy, leprosy remains a public health issue. The intradermal Bacillus Calmette-Guérin (BCG) vaccine, Mitsuda test (lepromin skin test), and anti-phenolic glycolipid I (PGL-I) serology are widely used in leprosy studies and have shown great epidemiologic...

Full description

Bibliographic Details
Main Authors: Sergio Araujo, Marina Monteiro Figueiredo Rezende, Diogo Carrijo Rodrigues de Sousa, Maraísa Resende Rosa, Danielle Cristina dos Santos, Luiz Ricardo Goulart, Isabela Maria Bernardes Goulart
Format: Article
Language:English
Published: Sociedade Brasileira de Medicina Tropical (SBMT) 2015-12-01
Series:Revista da Sociedade Brasileira de Medicina Tropical
Subjects:
Epidemiology
Leprosy
Immunology
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822015000600739&lng=en&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822015000600739&lng=en&tlng=en

Similar Items